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Abstract
Due to ethical concerns regarding animal testing, alternative methods have been in devel-
opment to test the efficacy and safety of pharmaceutical products and medications, specif-
ically topical (dermatological) medications. Two-dimensional (2D) and three-dimensional 
(3D) skin cell cultures are examples of in vitro methods used as an alternative to animal 
testing. The first skin cells cultured were keratinocytes, a type of cell predominantly in 
the epidermal layer of the skin. However, with differences in skin characteristics and 
pathophysiology of different skin conditions, various skin cell cultures and models to 
better mimic these differences have been developed. These cell cultures include not only 
keratinocytes but also other skin cell types, such as fibroblasts, which are predominantly 
in the dermal layer of the skin, and certain immune cells and even melanocytes. To have 
a better understanding of the type of cell cultures used for testing dermatological prod-
ucts, this chapter aims to outline the differences between 2D and 3D skin cell cultures 
while considering the advantages and disadvantages of each culture. Different types of 
cell culture models used for wound healing and for inflammatory skin conditions such as 
psoriasis will also be discussed.
Keywords: cell culture, 2D cell culture, 3D cell culture, skin cell culture, in vitro, topical, 
dermatological, wound healing, psoriasis
1. Introduction
The growth of cells in an environment outside of an organism’s body is referred to as a cell 
culture [1, 2]. Cells obtained from human tissues are often used for cell cultures to mimic 
the physiological and metabolic functions of humans for in vitro studies [3]. Cell cultures are 
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maintained in controlled environments and under controlled temperatures for cells to main-
tain their ability to survive and to grow [3]. For this reason, a medium for the cells to obtain 
the required nutrients for their growth is essential [2].
Cells obtained directly from living tissues and then cultured are referred to as primary cell 
cultures [4]. These cells have a short time frame of survival and scientific use [4]. Cells that 
have been modified to survive indefinitely with continuous cell division are referred to as 
either continuous cell lines [1] or immortalized cell lines [2]. Cancer cells are an example of 
the type of cells that may be used to create cell lines due to their genetic mutations and ability 
to divide continuously [2].
The very first cell cultures developed were of human skin which allowed for a better under-
standing of the physiological functions of the skin [5]. Cell cultures are available today in two-
dimensional (2D) and three-dimensional (3D) forms. Cell cultures that grow in controlled 
flat environments, such as a Petri dish, are 2D cell cultures [6]. Cell cultures that are 3D, 
however, combine and shape cells into a 3D form using a surrounding medium or special-
ized conditions to help maintain a 3D figure [7]. In vitro skin cell cultures developed initially 
were primarily 2D with keratinocytes as the primary cell types [8, 9]. In the epidermal layer, 
the main cell types are keratinocytes, while fibroblasts are the main cell types in the dermal 
layer of the skin [10]. It is thus evident that an in vitro model consisting of both keratinocytes 
and fibroblasts is required to better mimic the physiological functions of the human skin, 
especially with relation to the wound healing properties of the skin [5]. There are therefore 
ongoing efforts to develop various in vitro skin models that more closely resemble the skin’s 
physiological functions and that will allow for testing of dermatological products [8]. To have 
a better understanding of the type of cell cultures used for testing dermatological products, 
this chapter aims to outline the differences between 2D and 3D skin cell cultures while con-
sidering the advantages and disadvantages of each culture. Different types of cell cultures 
used for wound healing and for inflammatory skin conditions such as psoriasis will also be 
discussed.
2. 2D cell cultures
2D cell cultures have been the main type of cell cultures used by scientists in various fields 
for decades [6]. As explained in the introduction, cell cultures that grow in controlled flat 
environments, such as a Petri dish, are 2D cell cultures [6]. To maintain cells outside of an 
organism’s body, it is important to have the correct equipment and supplies to ensure the 
provision of an environment in which cells can survive and divide [2, 3]. Equipment involved 
typically includes a biosafety hood for maintaining the safety of cultures and of the individu-
als working with the cultures, a cell incubator for correct storage with a temperature of 37°C 
and 5% levels of CO2, a refrigerator for culture media and other supplies, and flasks or Petri dishes for placement of cells, amongst other required equipment [2, 3].
Besides having the correct equipment for adequate handling and storage of cell cultures, the 
culture medium or environment in which cell culture grow is also important. The cell culture 
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medium in 2D cell cultures initially consisted of blood plasma; however, over the years, syn-
thetic medium with the right amount of nutrients and even antifungal and antibiotic ingre-
dients have been developed [11]. Cell culture medium is expected to contain amino acids, a 
buffering system, vitamins, trace elements and more, to maintain cell viability [12]. Eagle’s 
minimum essential medium (EMEM) and Dulbecco’s modified Eagle’s medium (DMEM) are 
two examples of cell culture media that have been developed [13]. Different cell types may 
require different culture media, and thus, the nutrient requirements may vary [13].
2.1. 2D skin cell cultures
The very first cell cultures developed were derived from human skin and were of primarily 
keratinocytes [5, 8, 9]. As the largest organ in the human body, [14] the skin consists of the epi-
dermal and dermal layers [14, 15]. In the epidermal layer, the main cell types are keratinocytes, 
while fibroblasts are the main cell types in the dermal layer of the skin [10]. Initially, 2D skin cell 
cultures consisted primarily of keratinocytes [8, 9]. It was however determined that fibroblasts 
were essential for the growth of keratinocyte cultures [16] as fibroblasts are the cells responsible 
for secreting substances of the extracellular matrix such as collagen [17]. The primary fibroblast 
cell line, cultured by George Todardo and Howard Green, is known as the 3T3 cell line and was 
named based on its culturing method of transferring cultures every 3 days [16, 18]. The 3T3 cell 
line is typically used as a feeder layer in keratinocyte cultures [18]. HaCaT cells are a cell line 
of keratinocytes [19].
Prior to animal testing and clinical trials, traditionally, when testing pharmaceutical ingredi-
ents, the first step has been to test in vitro using 2D cell cultures [7]. This has however provided 
limitations with respect to testing as the results obtained from in vitro 2D cell culture studies 
have not translated to in vivo studies [7]. For this reason, in vitro 3D models have become 
increasingly popular as they are considered to more closely resemble in vivo processes [11, 20].
3. 3D cell cultures
Cell cultures that are 3D involve cells that are combined and shaped into a 3D form using a 
surrounding medium or specialized condition to help maintain the shape [7]. The equipment 
used for 2D cell cultures such as a biosafety hood, cell incubator with a temperature of 37°C 
and 95% O2, refrigerator for culture medium storage and other supplies [2, 3] may also be used for 3D cell cultures. Supplies used for 3D cultures which differ from those in 2D cell 
cultures include the matrices, scaffolds, and proprietary plasticware for aggregate formation 
(e.g., AlgiMatrix, microplates, and multidishes) [21]. Other supplies used in 3D cell cultures 
may include cell reagents for determining cell health and viability, such as the live/dead 
Viability/Cytotoxicity Kit and CellTracker Deep Red Dye by ThermoFisher Scientific [21].
The techniques used in creating 3D cell cultures are typically divided into methods that use 
a scaffold and methods that do not (Figure 1) [22]. Methods that do not use a scaffold are 
typically considered to be a better representation of in vivo activity as the cells in this method 
aggregate on their own [22]. When cells come together and aggregate, they are referred to as 
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a spheroid in 3D cell cultures [22, 23]. Some of the methods used in 3D cell cultures that will 
be further explained include the hanging drop method, agitation-based approaches, forced-
floating method, and the use of scaffolds [11, 24, 25]. Microfabricated 3D culture systems and 
bioprinting will also be discussed.
The hanging drop method provides a suspension of cells on a surface which is then inverted, 
allowing for the cells to hang and form cell-to-cell interactions and aggregate, forming spher-
oids [24, 25]. Another method is the utilization of continuous mixing methods in agitation-
based approaches, which allows cells to aggregate to one another to form a 3D cell culture, 
as a container that is moving will not allow the cells to stick to the walls of that container 
[11]. Another method of preventing cells from sticking to the container in which they are 
placed in is using the forced-floating method which involves the placement of a nonadhesive 
coating such as poly-2-hydroxyethyl methacrylate (poly-HEMA) or agar, which will in turn 
force the cells to form interactions and aggregate as opposed to sticking to the surface of the 
container [11].
The use of scaffolds is another method of forming 3D cell cultures [11]. Scaffolds are materi-
als with pores that allow cells to form aggregates [24]. Scaffolds can be prepared through 
different methods such as weaving and freeze drying [26] and are typically composed of 
Figure 1. Illustration of general 3D tissue culture methods (floating and matrix-based). Commercially available well-
plates and cell-support matrices are often used.
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gelatin, collagen, agarose, and fibronectin, amongst other materials [27]. The idea of scaf-
folds and matrices is to provide an imitation of the extracellular matrix, allowing for cells to 
grow and differentiate using these materials [27]. The extracellular matrix consists of essential 
substances, such as proteins, and surrounds cells in a fluid form that operates as a natural 
scaffold for cellular growth and differentiation [28, 29]. As discussed previously, fibroblasts in 
the body are the cells responsible for secreting extracellular matrix and the substances within 
it such as collagen [17].
Another type of 3D cell culture method is the microfabricated systems, also referred to as cells 
on chips, which uses microtechnology to provide cells with the required growth environment 
that can be easily controlled and uses microfluidics for providing nutrients [30]. Microfluidics 
is the handling of fluids within the microliters range [31]. Microfabricated systems have the 
advantage of being highly reproducible and provide a better control of the cell culture envi-
ronment [30]. Another advantage of microfabricated systems is greater cell-to-extracellular 
matrix interactions while requiring less cell culture [32].
Bioprinting is another method of developing 3D cell cultures. Bioprinting involves the printing 
of 3D systems by placing living cells in layers [33]. Bioprinting involves both a pre-processing 
stage as well as the printing stage [34]. The use of imaging diagnostics such as magnetic reso-
nance imagining (MRI), computed tomography (CT), and X-rays to scan an image of the organ 
or tissue of interest is the first step involved in bioprinting and is part of the pre-processing 
stage [33, 34]. Selecting the materials such as biomaterials (i.e., biopolymers) as well as cell 
selection is also part of the preprocessing stage [33, 34]. The printing stage is then completed 
using different methods such as inkjet printing [33, 35, 36]. Inkjet printing uses bioink for the 
process of bioprinting and may include the use of cells as the bioink [37, 38].
3.1. 3D skin cell cultures
As discussed previously, the results obtained from in vitro 2D monolayer cell culture models 
have not translated to in vivo successes [7]. Thus, alternative methods for testing dermato-
logical products have been sought out. According to an article by Bergers et al., [39] there are 
various 3D models that exist for a number of different dermatological conditions such as pso-
riasis and other autoimmune diseases. Skin cell cultures that are 3D have the advantages of 
containing a stratum corneum and thus the ability of testing pharmaceutical products on the 
stratum corneum as a skin barrier [40]. Another advantage to the use of 3D skin cell cultures is 
the longer cell culture use, which is usually between 10 and 30 days [40]. More recent human 
skin equivalent (HSE) cultures can even be used for up to 20 weeks [41]. The main disadvan-
tage to the use of 3D skin cell cultures however is the cost associated with developing these 
cultures [40]. The different types of 3D skin cell cultures that will be discussed in detail are 
histocultures, human skin equivalents, on-chip skin cultures, and pigmented cell cultures. A 
discussion on bioprinting of skin constructs is also included.
3.1.1. Histocultures
Histocultures are cultures of intact tissues that were developed to better mimic in vivo skin 
responses [42]. The process of hair growth is an example of the ability of histocultures to 
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mimic in vivo processes, as this process occurs in histocultures of skin cells and allows for 
the testing of pharmaceutical products aimed at inhibiting or improving hair growth [42]. 
The process of histocultures involves growing skin tissues on a growth medium on its own 
or with the support of collagen [42, 43]. Research has shown that both epidermal and dermal 
cells as well as hair follicles maintain their functions and physiology in skin histocultures [44]. 
Histocultures have thus successfully been used as in vitro models for testing dermatological 
products, particularly with respect to toxicity screening [42, 44].
3.1.2. Human skin equivalents
In order to test pharmaceutical products on the skin in vitro and provide suitable skin replace-
ment options for patients with various skin conditions, such as burn victims, HSEs were 
created [45]. HSEs are 3D cell culture models created from various human skin cells and 
materials that mimic the extracellular matrix [45] and are created as either epidermal equiva-
lents, dermal equivalents or skin equivalents consisting of both layers [8, 45]. Skin equivalents 
that are used as replacement skin for patients, known as skin grafts, are useful in conditions 
where the skin cannot adequately heal on its own, such as in the case of a burn victim or 
chronic ulcers/wounds [10].
An example of the method involved in developing full thickness human skin equivalents 
includes the isolation of keratinocytes and fibroblasts from donor skin which are then cul-
tured in medium at 37°C at 5% CO2 [46]. Keratinocytes are then incubated for 2 days fol-lowing their transfer onto a de-epidermized dermal equivalent and then placed at air-liquid 
interface for the development of full thickness human skin equivalent [46].
Currently available HSEs are primarily epidermal substitutes composed of keratinocytes in 
3D cell culture models such as Epiderm™, SkinEthic RHE™, and EpiSkin™, which are used 
for pharmaceutical and cosmetic testing of skin irritation from topical products [45, 47, 48]. 
As these skin substitutes are derived of only the epidermal layer and primarily keratinocytes, 
it limits their use for testing of products related to particular types of skin conditions that 
involve the immune system, including testing of products for wound healing [47]. Full thick-
ness models consisting of both the epidermal and dermal layers are thus beneficial [8]. One 
such model is the full thickness model developed by MatTeck Corporation, the EpidermFT™, 
which includes both normal human keratinocytes and fibroblasts cultured into a 3D model of 
several layers of the epidermis and dermis to more closely mimic human skin [49].
3.1.3. On-chip skin culture
Microfabricated systems, also referred to as cells on chips, are a type of 3D cell culture that 
uses microtechnology to provide cells with the required growth environment that can be 
easily controlled [30]. On-chip culturing also uses microfluidics for providing nutrients [30]. 
In order to mimic in vivo properties of the skin, an on-chip skin culture was created by Lee 
et al. [50] and is composed of a microfabricated cell culture of keratinocytes (HaCaT cells) and 
fibroblasts with microfluidic channels to mimic vasculature. This model provides an oppor-
tunity for dermatological medication testing on a microfabricated cell system as growth and 
differentiation of skin cells were made possible through this model [50]. Another on-chip skin 
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culture model with the ability to mimic vasculature is the model developed by Mori et al. [51], 
which includes vascular channels attached to an external perfusion system and can be used to 
test vascular absorption of topical products.
A comparison of on-chip cell cultures to traditional transwell skin cultures was completed by 
Song et al., [52] in which a static (no flow) chip, dynamic (flow, based on a gravity flow sys-
tem) chip, and transwell skin equivalents were compared. The comparison revealed that the 
static chip was not the ideal method as differentiation of skin did not occur and the epidermis 
was not attached by the end of 1 week [52]. It is thought that this is a result of lack of flow or 
perfusion in the static chip and thus insufficient flow of nutrients for the growth of the cells 
[52]. Thus an advantage to using microfabricated skin cell cultures vs. typical 3D cell cultures 
is the provision of microfluidics which can aid in the supply of essential nutrients for the 
growth and differentiation of skin cells as well as more closely mimicking in vivo processes 
such as vasculature [51, 52].
3.1.4. Pigmented skin cell cultures
A reconstructed pigmented human skin model was developed by Duval et al. [53]. Using a 
dermal equivalent with a steel ring on top, seeding of human keratinocytes and melanocytes 
was completed [53]. The culture developed a monolayer after a period of 1 week in medium 
after which it was exposed to air for another week to allow differentiation of keratinocytes 
[53]. This 3D model allows for a better understanding of the interactions between melano-
cytes, keratinocytes, and fibroblasts [53] and also allows for a pigmented human skin model 
that could potentially be used for testing of pharmaceutical products on pigmented skin.
3.1.5. Bioprinting of skin constructs
The process of bioprinting explained above is still the same process followed for bioprinting 
of skin constructs. An important consideration, however, in the pre-processing stage, is that 
the imaging equipment used ideally should be able to differentiate skin color [34]. Also, with 
respect to cell selection, keratinocytes are the primary cell types used for bioprinting of skin 
cells [34]. The advantages to using bioprinting of skin constructs includes greater accuracy 
in placement of cells and extracellular matrix as well as having the potential of imbedding 
vasculature in the skin construct as bioprinting of vasculature is also possible [54]. Skin con-
structs made through bioprinting are also considered to have great plasticity [54]. Skin bio-
printing may also be used for developing 3D models for drug testing, such as diseased skin 
models, and are believed to provide more uniform models compared to manually developed 
skin models [55]. The main disadvantage of bioprinting for skin constructs is the high cost 
associated with its use [54].
4. Skin cell cultures for wound healing
Wound healing is a physiological process that consists of four phases: hemostasis, inflamma-
tion, proliferation, and remodeling [56]. In the first phase, after a wound injury, hemostasis, 
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platelets are activated and migrated to the site of injury [57]. The second phase, inflammation, 
begins about 1 day postinjury and inflammatory mediators such as histamine are released, pro-
viding the typical traits of inflammation such as heat and swelling [57]. Proliferation is the phase 
in which granulation tissue forms at the site of injury and after which re-epithelization occurs 
[58]. In the last phase, remodeling of the tissue occurs to improve the strength of the skin tissue, 
which is only ever within 80% of the original tissue’s strength [58]. The normal wound heal-
ing process could be affected, however, leading to chronic ulcers or excessive wound healing 
resulting in hypertrophic scars [59]. For this reason, topical agents to improve wound healing 
or reduce scarring may be of interest and as such in vitro testing models for wound healing will 
be discussed.
Both 2D and 3D skin cell cultures are available as wound healing models [60]. 2D wound 
healing models involve the creation of a site of injury in a monolayer of skin cells, either 
through mechanical or chemical means, in which cells then migrate to the site of injury 
[60, 61]. Cells in 2D monolayer cultures are thought to adhere to the flat environments, 
such as a Petri dish, in which they are cultured and will therefore migrate to areas of 
free space within the dish, an activity thought to mimic in vivo migration involved in 
cell differentiation [62]. One method of mechanical introduction of a wound to a 2D cell 
culture is through the scratch assay that utilizes materials such as pipette tips or needles 
to introduce a wound or scratch into the monolayer cell culture [63, 64]. Images of the 
wound are taken within set time frames to assess the migration of cells [63]. Typically, 
however, it is difficult to ensure wounds that are equal in size using this method [63], and 
thus for this reason, testing of pharmaceutical products on these types of cultures are not 
ideal. 2D skin cell cultures also lack essential functions that could mimic in vivo processes, 
such as immune functionality and blood perfusion [65]. 3D wound healing models have 
thus attempted to more closely mimic in vivo wound healing processes and are available 
as histocultures or HSEs.
Histocultures are cultures of intact tissues, consisting of more than one type of skin cell, 
such as neutrophils and other cells involved in wound healing, and are thus able to better 
mimic in vivo skin responses of wound healing [42, 43]. HSEs, on the other hand, are 3D cell 
culture models created from various human skin cells and materials that mimic the extracel-
lular matrix [45] and are created as either epidermal equivalents, dermal equivalents or skin 
equivalents consisting of both layers [8, 45]. Some examples of 3D wound healing skin cell 
cultures and HSEs are described below.
A 3D wound healing skin equivalent developed by Herman et al. [66] included capillary 
endothelial cells which were capable of creating a similar formation to in vivo capillaries in 
the skin. This wound healing model involved several different cells, such as keratinocytes and 
epithelial cells, and used 3D matrices composed of Matrigel™ and collagen [66]. As angio-
genesis is involved in the process of wound healing [66], this model is an excellent example 
of improved 3D wound healing cell culturing protocols to more closely mimic in vivo wound 
healing processes.
Another example of a 3D skin cell culture model that could be used for wound healing was 
reported by Sidgwick et al. [67]. This model allows for the immersion of biopsies in Williams 
E culture media with the epidermal layer of the skin uncovered and uses whole tissue biopsies 
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in 24-well cell plates with transwell inserts [67]. This model allows application of topical 
medications to the uncovered epidermal layer and is thus useful for testing of pharmaceutical 
products, including those used for transdermal drug delivery [67].
The skin substitutes derived of only the epidermal layer and primarily keratinocytes, however, 
are limited in their use for testing of products related to particular types of skin conditions that 
involve the immune system, including the testing of products for wound healing [47]. Full 
thickness models consisting of both the epidermal and dermal layers are thus beneficial [8]. One 
such model is the full thickness model developed by MatTeck Corporation, the EpidermFT™ 
which includes both normal human keratinocytes and fibroblasts cultured into a 3D model 
of several layers of the epidermis and dermis to more closely mimic human skin [49]. This kit 
can be purchased with a wound healing assay kit [49] and is thus a commercially available 3D 
model for testing of dermatological products aimed at wound healing.
It is thus evident from the examples provided in this section that 3D wound healing models 
more closely mimic in vivo wound healing processes and thus may be a better choice for 
testing of pharmaceutical products aimed at wound healing. Wound healing models are also 
commercially available which may improve the use of in vitro models as a replacement for 
animal testing.
5. Skin cell cultures for psoriasis
As an inflammatory skin condition that involves the immune system, psoriasis has the charac-
teristic appearance of silver scales that arise from increased proliferation of the keratinocytes 
in the epidermal layer [68, 69]. Psoriasis is typically treated with topical steroid medications 
or with vitamin D analogue medications such as calcipotriol as well as with moisturizing 
agents [68]. The treatment of psoriasis also includes systemic medications that suppress the 
immune system such as methotrexate and cyclosporine as well as biologic drugs [68, 70].
Psoriasis has been linked to various mental health illnesses such as anxiety and depression 
which are thought to result from having a chronic visible skin condition [71], and therefore the 
need for developing new pharmaceutical products and testing of these products is evident. 
As psoriasis is primarily treated with topical medications [70], having in vitro cell cultures or 
models for testing the safety and efficacy of these topical medications is essential.
Skin cell cultures that are 2D for dermatological conditions such as psoriasis and other auto-
immune disorders exist [39]. 2D cell cultures of psoriasis initially consisted of psoriatic kerati-
nocytes; however, this proved to be an ineffective model for psoriasis as the cells were not able 
to grow and lost their psoriatic genes with time [72]. As a result, alternative methods such as 
adding cytokines to normal human keratinocytes to induce psoriatic features were developed 
[73]. As stated previously, however, testing of medications on 2D cell culture models does not 
always translate to in vivo responses [7], and thus, 3D models to better mimic in vivo responses 
for testing of topical medications for psoriasis have been developed.
Barker et al. [74] introduce an in vitro model of psoriatic human skin, whereby a monolayer 
cell culture of psoriatic keratinocytes on top of collagen and fibroblasts from the dermis was 
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created, onto which an epidermal layer was formed approximately 3 weeks later. Similarly, a 
3D skin substitute using psoriatic skin cells was developed by Jean et al. [75] with either both 
psoriatic keratinocytes and fibroblasts or only one type of psoriatic cells (either keratinocytes 
or fibroblasts were psoriatic). Skin biopsies were obtained from patients with plaque psoria-
sis, and keratinocytes were extracted and seeded on to mouse fibroblasts and incubated at a 
temperature of 37°C [75]. For skin substitutes, ascorbic acid was used to culture the fibroblasts 
which formed dermal sheets that were altered to create a dermal layer onto which keratino-
cytes were then seeded to form an epidermal layer [75]. This method is the self-assembly 
method as the fibroblasts release their own extracellular matrix to maintain their growth [75]. 
A serum-free 3D psoriatic skin cell culture was similarly developed by Duque-Fernandez 
et al. [66]. This method is similar to the one presented by Jean et al. [75] and may be due to 
the fact that some authors are the same in both articles. The model by Duque-Fernandez et al. 
[76] was even used for testing percutaneous permeation of benzoic acid, caffeine, and hydro-
cortisone, using a Franz-diffusion cell method. This was compared to healthy skin substitutes 
and revealed that the psoriatic skin substitute had a greater permeability response to the three 
compounds [76].
For safety and efficacy testing of medications for psoriasis, commercially available 3D in vitro 
models also exist. Two examples of such models are the Psoriasis Skin Model by Creative 
Bioarray [77] and the model by MatTek Corporation [78]. According to Creative Bioarray [77], 
their skin model more closely mimics in vivo psoriatic skin vs. typical cell cultures as it allows 
for cell differentiation and can be used for testing of pharmaceutical products. The psoriasis 
model by MatTek Corporation can also be used for testing of dermatological products as it 
a 3D model composed of psoriatic fibroblasts while using normal human epidermal kerati-
nocytes and is capable of mimicking in vivo psoriatic responses such as basal cell prolifera-
tion [78]. These examples were presented for a better understanding of the methods used in 
developing psoriatic human skin equivalents as well as the commercially available models for 
testing the safety and efficacy of dermatological products used for psoriasis.
6. 2D vs. 3D cell cultures: morphology and other characteristics
Cell cultures that are 2D and 3D clearly differ with respect to their cell morphology as well 
as other characteristics. Cell cultures that grow in controlled flat environments, such as a 
Petri dish, are 2D cell cultures [6], and as such have cells that are flat in morphology [7]. Cell 
cultures that are 3D involve cells that are combined and shaped into a 3D spheroids using 
surrounding milieu or specialized conditions [7]. Cell viability also differs between 2D and 3D 
cell cultures. For example, 2D breast cancer cell cultures showed greater cell viability than 3D 
breast cancer cells [79]. Drug efficacy may also differ in 2D and 3D cell cultures [79].
7. 2D vs. 3D cell cultures: advantages and disadvantages
Monolayer 2D cell cultures do not always provide an accurate representation of in vivo pro-
cesses [7]. The use of a single cell type [80], such as the use of keratinocytes only in skin cell 
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cultures, [8] or the lack of interactions in 2D cell cultures of cell-to-cell or cell-to-extracellular 
matrix may be possible causes [5, 80]. However, advantages to using a 2D cell culture include 
ease of use, cost, and abundant scientific literature surrounding its use [81, 82].
3D cell cultures, on the other hand, provide a better imitation of in vivo processes as they allow for 
better understanding of the interactions that take place between cell-to-cell and cell-to-extracel-
lular matrix [7]. Cell cultures that are 3D have also revealed to possess gene expression abilities, 
thus mimicking in vivo processes [83]. However, regardless of their improvements vs. the 2D cell 
cultures, typically 3D cell cultures still lack in their ability to provide key functions such as cel-
lular waste removal [7]. Microfabricated cell cultures or on-chip cell cultures are advantageous 
in this instance as they provide microfluidic channels that enable the flow of nutrients and waste 
removal as well as the ability to mimic vasculature [51, 52]. Thus microfabricated 3D cell cultures 
are arguably the in vitro method of cell cultures that most closely mimic in vivo processes [50].
With respect to skin cell cultures, those that are 3D have the advantages of containing a stra-
tum corneum and thus the ability of testing pharmaceutical products on the stratum corneum 
Advantages Disadvantages
2D cell 
cultures
• Ease of use, cost and abundant scientific literature 
surrounding use [81, 82]
• Do not always provide an accurate 
representation of in vivo processes [7]
• Use of a single cell type, [80] for example 
with skin cell cultures, the use of keratino-
cytes only [8]
• No cell-to-cell or cell-to-extracellular 
matrix interactions [5, 80]
3D cell 
cultures
• Better imitation of in vivo processes [7]
• Better understanding of the interactions that take 
place between cell-to-cell and cell-to-extracellular 
matrix [7]
• Possess gene expression abilities, thus mimicking in 
vivo processes [83]
• Microfabricated cell cultures or on-chip cell cultures 
provide microfluidic channels that enable the flow 
of nutrients and waste removal as well as the ability 
to mimic vasculature [51, 52]
• 3D skin cultures have a stratum corneum and thus 
the ability of testing pharmaceutical products on the 
stratum corneum as a skin barrier [40]
• Longer skin cell culture use between 10 and 30 days 
[40]; more recent human skin equivalent (HSE) 
cultures can even be used for up to 20 weeks [41]
• 3D bioprinting provides greater accuracy in place-
ment of cells and extracellular matrix, potential of 
imbedding vasculature in the skin construct and 
have great plasticity [54]
• 3D bioprinted skin models provide more uniform 
models vs. manually developed skin models [55]
• Typically lack in their ability to provide 
key functions such as cellular waste 
removal [7]
• Cost associated with developing cultures 
[40, 54]
Table 1. Summary of the advantages and disadvantages of 2D vs. 3D cell cultures.
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as a skin barrier [40]. Other advantages to the use of 3D skin cell cultures include longer cell 
culture use between 10 and 30 days [40]. More recent human skin equivalent (HSE) cultures 
can even be used for up to 20 weeks [41]. Skin substitutes that are derived from only the 
epidermal layer and primarily keratinocytes are limited in their use for testing of products 
related to particular types of skin conditions that involve the immune system, including test-
ing of products for wound healing [47]. Full thickness models consisting of both the epidermal 
and dermal layers are thus beneficial [8]. 3D bioprinting of skin constructs are also advanta-
geous as they provide a greater accuracy in placement of cells and extracellular matrices as 
well as having the potential of imbedding vasculature in the skin construct as bioprinting of 
vasculature is also possible [54]. Skin constructs made through bioprinting are also consid-
ered to have high plasticity [54]. Skin bioprinting may also be used for developing 3D models 
for drug testing, such as diseased skin models, and are considered to provide more uniform 
models vs. manually developed skin models [55]. The primary disadvantage to the use of 3D 
skin cell cultures, however, is the cost associated with developing these cultures [40, 54]. See 
Table 1 for a summary of the information presented in this section.
8. Conclusion
Testing the efficacy and safety of dermatological products and medications using in vitro 
methods such as cell cultures can be considered as a replacement to animal testing. Cell cul-
tures currently exist in both 2D and 3D forms. The very first cell cultures developed were of 
human skin which allowed for a better understanding of the physiological functions of the 
skin [5]. In vitro skin cell cultures developed initially were primarily 2D with keratinocytes as 
the primary cell types used [8, 9]. However, it became evident that an in vitro model consisting 
of both keratinocytes and fibroblasts is required to better mimic the physiological functions of 
the human skin, especially with relation to the wound healing properties of the skin [5]. For 
this reason, 3D cell cultures that allowed greater cell-to-cell and cell-to-extracellular matrix 
interactions were developed [7].
It is evident from the information presented in this chapter that 3D skin cell cultures can more 
closely mimic in vivo processes vs. 2D skin cell cultures for both wound healing and psoriasis. 
In addition, full thickness 3D skin equivalents that consist of both an epidermal and dermal 
layer are a better representation of the human skin [8]. Microfabricated cell systems, however, 
provide arguably an even better model for mimicking in vivo skin processes including vas-
culature and thus allowing for the testing of absorption of pharmaceutical products [50–52]. 
Additionally, 3D bioprinting provides greater accuracy in placement of cells and extracellular 
matrices along with the potential of imbedding vasculature in the skin construct as well as 
having great plasticity [54]. 3D bioprinted skin models also provide more uniform models vs. 
manually developed skin models [55].
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